Hadly Clark
Director FasterCures, Milken Institute
Seminars
Thursday 5th February 2026
Tackling Policy Issues to Ensure Patient Access to Testing & Facilitate Longitudinal Monitoring
1:30 pm
- Assessing the limitations of the current policy environment for liquid biopsies, especially for serial monitoring
- How to influence and overcome policy issues preventing patient access to therapeutics
- What are the realistic milestones to hit to expedite better patient access to better drug-diagnostics?
Wednesday 4th February 2026
Panel Discussion: Bridging the Gap from Innovation to Access by Aligning Standardization, Policy & Reimbursement for Liquid Biopsy
12:30 pm
- Uncovering how inconsistent definitions, metrics, and data standards are hindering payer confidence and policy support for liquid biopsy
- Exploring the role of pre-competitive collaboration in driving standardization to unlock broader reimbursement and clinical adoption
- Identifying immediate policy actions and evidence needs to align stakeholders and accelerate access to serial testing and early detection
